Posted by Michael Wonder on 28 Nov 2023
ICER releases draft evidence report on treatment for schizophrenia
28 November 2023 - Public comment period now open until 22 December 2023; requests to make oral comment during public meeting also being accepted.
The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of xanomeline tartrate/trospium chloride (KarXT, Karuna Therapeutics) for the treatment of schizophrenia.
